SPRi 3 - ≥98%(HPLC), high purity , CAS No.1292285-54-1, Inhibitor of sepiapterin reductase

Item Number
S287577
Grouped product items
SKUSizeAvailabilityPrice Qty
S287577-1mg
1mg
Available within 8-12 weeks(?)
Production requires sourcing of materials. We appreciate your patience and understanding.
$39.90
S287577-5mg
5mg
Available within 8-12 weeks(?)
Production requires sourcing of materials. We appreciate your patience and understanding.
$110.90
S287577-10mg
10mg
Available within 8-12 weeks(?)
Production requires sourcing of materials. We appreciate your patience and understanding.
$166.90
S287577-25mg
25mg
Available within 8-12 weeks(?)
Production requires sourcing of materials. We appreciate your patience and understanding.
$365.90
S287577-50mg
50mg
Available within 8-12 weeks(?)
Production requires sourcing of materials. We appreciate your patience and understanding.
$658.90

Potent sepiapterin reductase (SPR) inhibitor; attenuates proliferation of CD4+ T cells

View related series
sepiapterin reductase Inhibitor

Basic Description

SynonymsSPR inhibitor 3;SPRi3
Specifications & PurityMoligand™, ≥98%(HPLC)
Biochemical and Physiological MechanismsPotent sepiapterin reductase (SPR) inhibitor (IC50= 53 - 74 nM for human SPR). Inhibits BH4 synthesis pathway and attenuates proliferation in naive CD4+T cells. Suppresses proliferation of human effector CD4+T cells following stimulation. Reduces SPR acti
Storage TempStore at -20°C,Argon charged
Shipped InIce chest + Ice pads
GradeMoligand™
Action TypeINHIBITOR
Mechanism of actionInhibitor of sepiapterin reductase
Product Description

SPR inhibitor 3 (SPRi3) is a potent sepiapterin reductase (SPR) inhibitor. SPR inhibitor 3 (SPRi3) displays high binding affinity to human SPR in a cell-free assay (IC50=74 nM) and efficiently reduces biopterin levels in a cell-based assay (IC50=5.2 μM). SPR inhibitor 3 (SPRi3) reduces neuropathic and inflammatory pain through a reduction of BH4 levels.

Associated Targets(Human)

SPR Tchem Sepiapterin reductase (4 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Names and Identifiers

IUPAC Name N-[2-(5-hydroxy-2-methyl-1H-indol-3-yl)ethyl]-2-methoxyacetamide
INCHI InChI=1S/C14H18N2O3/c1-9-11(5-6-15-14(18)8-19-2)12-7-10(17)3-4-13(12)16-9/h3-4,7,16-17H,5-6,8H2,1-2H3,(H,15,18)
InChi Key YBXBWBBVLXZQBJ-UHFFFAOYSA-N
Canonical SMILES CC1=C(C2=C(N1)C=CC(=C2)O)CCNC(=O)COC
Isomeric SMILES CC1=C(C2=C(N1)C=CC(=C2)O)CCNC(=O)COC
PubChem CID 52911386
Molecular Weight 262.30

Certificates

Certificate of Analysis(COA)

Enter Lot Number to search for COA:

Chemical and Physical Properties

SolubilitySolvent:DMSO, Max Conc. mg/mL: 26.23, Max Conc. mM: 100; Solvent:ethanol, Max Conc. mg/mL: 26.23, Max Conc. mM: 100

Related Documents

References

1. Latremoliere A, Latini A, Andrews N, Cronin SJ, Fujita M, Gorska K, Hovius R, Romero C, Chuaiphichai S, Painter M et al..  (2015)  Reduction of Neuropathic and Inflammatory Pain through Inhibition of the Tetrahydrobiopterin Pathway..  Neuron,  86  (6): (1393-406).  [PMID:26087165] [10.1021/op500134e]
2. Haruki H, Hovius R, Pedersen MG, Johnsson K.  (2016)  Tetrahydrobiopterin Biosynthesis as a Potential Target of the Kynurenine Pathway Metabolite Xanthurenic Acid..  J Biol Chem,  291  (2): (652-7).  [PMID:26565027] [10.1021/op500134e]

Solution Calculators